Gevo Declines on Plans to Raise Up to $100 Million

Gevo Inc., the U.S. biotechnology company backed by the French oil company Total SA and the specialty chemicals maker Lanxess AG, fell the most on record after announcing plans to raise more capital to retrofit a plant in South Dakota.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.